Brain Scientific Inc.
BRSF
$0.75
-$0.35-31.82%
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | 214.60K | 460.80K | 454.70K | 423.90K | 265.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 214.60K | 460.80K | 454.70K | 423.90K | 265.80K |
| Cost of Revenue | 160.30K | 323.50K | 323.50K | 288.60K | 182.50K |
| Gross Profit | 54.30K | 137.40K | 131.10K | 135.20K | 83.20K |
| SG&A Expenses | 9.36M | 12.99M | 10.70M | 9.64M | 8.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.82M | 13.72M | 11.43M | 10.27M | 8.92M |
| Operating Income | -9.61M | -13.26M | -10.97M | -9.84M | -8.66M |
| Income Before Tax | -12.34M | -14.64M | -12.00M | -10.61M | -9.10M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.34 | -14.64 | -12.00 | -10.61 | -9.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.34M | -14.64M | -12.00M | -10.61M | -9.10M |
| EBIT | -9.61M | -13.26M | -10.97M | -9.84M | -8.66M |
| EBITDA | -8.78M | -12.46M | -10.36M | -9.43M | -8.44M |
| EPS Basic | -13.29 | -24.11 | -25.72 | -25.45 | -23.70 |
| Normalized Basic EPS | -7.95 | -15.07 | -16.08 | -15.91 | -15.02 |
| EPS Diluted | -13.29 | -24.11 | -25.72 | -25.45 | -23.70 |
| Normalized Diluted EPS | -7.95 | -15.07 | -16.08 | -15.91 | -15.02 |
| Average Basic Shares Outstanding | 3.81M | 2.97M | 2.07M | 1.70M | 1.45M |
| Average Diluted Shares Outstanding | 3.81M | 2.97M | 2.07M | 1.70M | 1.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |